Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract
science-forward company developing infusion and delivery technologies, today
announced information on its Project Varin, a nearly complete research program
implemented to develop novel production technologies for rare cannabinoids,
including tetrahydrocannabivarin (“THC-V”), which is not scheduled at the
federal level. According to the update, the program has produced meaningful
technology breakthroughs resulting in several patent filings. The company has
been able to leverage these technological developments to significantly reduce
the cost of exotic cannabinoids on a per-serving basis resulting in a greater
than 50% expected cost advantage. “We think we have rewritten the exotic
cannabinoid cost equation via our Project Varin. The minor exotics represent a
new cost challenge for the industry, and we believe we have developed a strong
and defensible solution,” Arman Tabatabaei, CEO of Cannabis Global, stated in
the news release. “Acquiring THC and CBD from plants within the Cannabaceae
family is relatively easy as these cannabinoids are produced by nature in
abundance. It is a very different issue relative to THC-V, CBN, and other
exotics. With our patent pending technologies, we have been able to rewrite the
cost equation for minor cannabinoids, while at the same time moving well beyond
the purity possible from legacy technologies. While we are already at a 50%
cost advantage to the competing technologies, most of which are still
theoretical and not yet available on the market, we believe further travel down
our cost curve is possible as we move into high volume manufacturing this
month.”
To view the full press release, visit http://ibn.fm/aFYfy
About Cannabis Global, Inc.
Cannabis Global, Inc., formerly known as MCTC Holdings,
Inc., is a fully audited and reporting company with the U.S. Securities &
Exchange Commission, trading with the stock symbol MCTC. The company is an
emerging force in the area of cannabinoid sciences and highly bioavailable hemp
and cannabis infusion technologies. The company does not engage in the
production, distribution, or sales of any controlled substances, including
marijuana. The company has an actively growing portfolio of intellectual
property having filed six patents in the areas of cannabinoid delivery systems
and cannabinoid polymeric nanoparticles. The company markets its consumer
products under the Hemp You Can Feel brand name. Cannabis Global launched is
Project Varin early in 2020, to develop new delivery methods for rare
cannabinoid Tetrahydrocannabivarin (“THC-V”) and to develop products based on
this cannabinoid. For more information, visit the company’s website at www.CannabisGlobalInc.com.
NOTE TO INVESTORS: The latest news and updates
relating to MCTC are available in the company’s newsroom at http://ibn.fm/MCTC
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment